If cannabis rescheduling is finalized, what actually happens next — and how does medical cannabis realistically get implemented in the United States? On this episode of Trade To Black, presented by Flowhub, Shadd and Anthony are joined on the show by Aras Azadian, CEO of Avicanna Inc (TSX: AVCN | OTCQX: AVCNF), a company that has focused exclusively on medical cannabis research and clinical development since its founding.
Hosts Shadd Dales and Anthony Varrell shift the conversation away from stock price speculation and toward something far more complex: execution. Specifically, how a Schedule III framework would work in practice for medical cannabis, an area many investors and operators still don’t fully understand.
Aras Azadian is the CEO of a company that has focused exclusively on medical cannabis research and clinical development since its founding. Operating in Canada — where cannabis is federally legal — Avicanna Inc, has spent more than a decade working with physicians, hospitals, insurers, and regulators to build evidence-based medical cannabis programs.
The discussion with Azadian compares Canada’s structured medical system with the fragmented U.S. model, highlighting the real work required beyond rescheduling: physician education, clinical guidelines, reimbursement conversations, intellectual property, and partnerships with medical institutions.
We also discuss Avicanna’s real-world evidence studies, including oncology-focused research and published data showing cannabinoids’ ability to address multiple symptoms at once, such as pain, sleep disruption, anxiety, and epilepsy.
Rather than treating rescheduling as a finish line, the episode frames it as the starting point for infrastructure investment, collaboration with pharmaceutical and medical institutions, and a more disciplined medical pathway in the U.S.
In the second segment, Flowhub CEO Kyle Sherman joins the conversation to discuss what these regulatory shifts could mean for operators trying to build durable, compliant cannabis businesses in a changing market. This episode is about how rescheduling actually works — not just what it means on paper.
You won’t want to miss this episode.
